menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Testing to Trace Cancers of Unknown Primary Origin

close
Testing to Trace Cancers of Unknown Primary Origin
Restart
Resume
Read full article
Choose a format
Media formats available:
A pre-test is required to view this content.
A pre-survey is required to view this content.
Details
Presenters
Comments
  • Overview

    Cancer is so often an agonizing diagnosis, one that can be that much more difficult for a patient to accept when the origin of the cancer cannot be traced. Novel genetic tests are just one of a few new options that may help us in situations where imaging, therapy, and other genetic markers have not been effective. Dr. F. Anthony Greco, director of the Sarah Cannon Cancer Center in Nashville, tells us that we appear to be making progress toward new ways to diagnose cancers of unknown primary origin. Dr. Larry Kaskel hosts.

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    Cancer is so often an agonizing diagnosis, one that can be that much more difficult for a patient to accept when the origin of the cancer cannot be traced. Novel genetic tests are just one of a few new options that may help us in situations where imaging, therapy, and other genetic markers have not been effective. Dr. F. Anthony Greco, director of the Sarah Cannon Cancer Center in Nashville, tells us that we appear to be making progress toward new ways to diagnose cancers of unknown primary origin. Dr. Larry Kaskel hosts.

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 3/7/21